Riyadh skyline with the King Abdullah Financial District and Kingdom Tower, Saudi Arabia, a country with a high burden of type 2 diabetes in MENAPhoto: B.alotaby, CC BY-SA 4.0, via <a href="https://commons.wikimedia.org/wiki/File:Riyadh_Skyline_showing_the_King_Abdullah_Financial_District_(KAFD)_and_the_famous_Kingdom_Tower_.jpg">Wikimedia Commons</a>

The age-standardised prevalence of type 2 diabetes in MENA, the Middle East and North Africa, more than doubled between 1990 and 2023, from 5.57% to 11.51%, according to an analysis of Global Burden of Disease data led by researchers at the King Abdullah International Medical Research Center in Saudi Arabia. The study, published in the International Journal of Public Health, shows a burden that is still rising in many countries, with long-term consequences for the region’s foot care services.

What the data show on type 2 diabetes in MENA

Alshahrani and colleagues grouped MENA countries into four subregions: Turkey, the Levant, North Africa, and the Gulf and adjacent West Asia. Across the region, the age-standardised death rate from type 2 diabetes rose from 26.13 per 100,000 people in 1990 to about 30.16 in 2023, after peaking in 2016.

Disability-adjusted life years (DALYs), a measure of healthy years lost to illness and early death, rose by about 81% among men, from 840.53 to 1,518.81 per 100,000. Among women, the rate rose by about 29%, from 1,080.63 to 1,396.25, narrowing the gap between the sexes.

Country hotspots

In 2023, Bahrain (3,436 per 100,000) and Saudi Arabia (2,613) had the highest DALY rates in the Gulf, while Qatar peaked around 2006 to 2008 and has since declined to 1,979.46. In the Levant, Palestine (2,083.03) and Jordan (1,537.42) had the highest rates. Egypt and Tunisia recorded the largest increases in North Africa. Turkey’s rates were stable until about 2019 and then accelerated sharply, and Iran and Yemen had low but rising rates.

The authors note that the study is ecological and based on modelled estimates, so it cannot establish the causes of these trends.

The foot connection

The paper does not report foot complications, but they follow diabetes closely. Peripheral neuropathy and peripheral arterial disease develop over years of raised blood glucose, so today’s rise in type 2 diabetes in MENA points to more people at risk of ulceration, infection and amputation in the decade ahead. Several countries in the region are already responding, including Saudi Arabia, which has launched its Walk Safe national diabetic foot programme.

IMEA POD Perspective

These numbers on type 2 diabetes in MENA should be read as a workforce forecast. Bahrain and Saudi Arabia carry the heaviest type 2 diabetes burden in the region, yet podiatry remains a small profession across most of MENA, with few local degree programmes and a heavy reliance on internationally trained staff. Health ministries planning for diabetes need to plan for feet: annual foot screening in primary care, clear referral routes to multidisciplinary foot teams, local podiatry training, and recognised roles for foot care assistants who can deliver routine nail and callus care. The narrowing gap between men and women matters too. Foot screening must be accessible to women, including through female clinicians where that is the cultural expectation. Countries such as Egypt and Tunisia, where the burden is rising fastest, have a window to build foot care capacity before complication rates climb. Preventing diabetes remains the biggest lever, but the people already living with it need foot care now.

Sources and further reading

Leave a Reply